Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 103 | 1 | 89 | −13 |
| Shares | 9.05M | 6.46K | 6.60M | −2.44M (−27.0%) |
| Value | $78.4M | $56.0K | $31.0M | −$47.3M (−60.4%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 359,697 | $1.65M | 0.00% |
| Bank of Montreal | 249,200 | $1.35M | 0.00% |
| Ergoteles LLC | 224,700 | $1.03M | 0.03% |
| Squarepoint Ops LLC | 116,065 | $532.0K | 0.00% |
| Belvedere Trading LLC | 40,690 | $343.0K | 0.37% |
| SG Americas Securities, LLC | 46,532 | $213.0K | 0.00% |
| Virtu Financial LLC | 26,661 | $122.0K | 0.01% |
| Simplex Trading, LLC | 20,363 | $93.0K | 0.00% |
| Marshall Wace, LLP | 19,509 | $90.0K | 0.00% |
| XTX Topco Ltd | 18,174 | $83.0K | 0.03% |
| LMR Partners LLP | 13,307 | $61.0K | 0.00% |
| Laurion Capital Management LP | 12,393 | $57.0K | 0.00% |
| Balyasny Asset Management LLC | 11,627 | $53.0K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 11,184 | $51.0K | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 10,572 | $48.0K | 0.00% |
| Group One Trading, L.P. | 8,026 | $37.0K | 0.00% |
| Urban Wealth Management, LLC | 2,858 | $13.0K | 0.04% |
| Quantbot Technologies LP | 742 | $3.00K | 0.00% |
| ACG Wealth | 400 | $2.00K | 0.00% |
| Brown Brothers Harriman & Co | 8 | $0 | 0.00% |
Sold out (33)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (1)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 6,457 | $56.0K |